• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Chennai , Aug. 20

GRANDIX Pharma, a company owned by 490 doctors, is to open a formulation plant shortly on the outskirts of Chennai. The Rs 11-crore plant has been designed and built to meet US regulatory norms.

Grandix's shareholders are all doctors, and the company has been engaged in marketing formulations since 1996.

The new plant, which has a capacity of 9 million tablets a day, would make tablets in therapeutic segments outside of antibiotics, said Dr A. Ramamurthy, Managing Director of Grandix, at a press conference here on Friday.

The company has begun the process of getting the plant approved by the US drug regulator as it plans to eventually seek a market there. In the meantime, about 50 per cent of the plant's output would be earmarked for exports to less regulated markets, said officials.

More Stories on : New Projects | Pharmaceuticals | Tamil Nadu

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
IVRCL to raise Rs 150 cr via book-building

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line